Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.
about
Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnoverDeubiquitinases: Novel Therapeutic Targets in Immune Surveillance?CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response.The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development.Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasomeThe Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exitRegulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination.USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy.The role of ubiquitin-binding domains in human pathophysiology.The repertoires of ubiquitinating and deubiquitinating enzymes in eukaryotic genomes.Divide and rule: The role of ubiquitination in inactivation of the ERK5-MAPK cascade.Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1Specific expression of k63-linked ubiquitination of calmodulin-like protein 5 in breast cancer of premenopausal patients.The post-translational modification, SUMOylation, and cancer (Review).
P2860
Q24303432-89730A4A-0C06-4B32-A124-992673A95D3CQ28069021-04014358-1726-49DE-AAB9-527EB2BEE1E2Q33688623-F0769A37-709C-4ABC-BED3-965499716D65Q34784606-30165EE3-C457-414E-A12A-B726FBAF11D9Q35207348-49E468AC-D411-4092-924A-41AA4F263399Q36278724-6516C54C-78FA-4203-9B7A-E6C1BF6A902DQ37075932-C1EDF650-C4D1-4DEB-A735-5E73DCD8AF5DQ38119185-168DC9BE-935F-4651-B3B8-3FCBBE4EC176Q38128426-ADB2857F-1EC3-4577-B593-48A18554CDE5Q38217924-5AF72487-36B8-44EC-B6BF-C7141BC046D8Q41436775-8BAB68F7-E85E-4995-9A98-EDDF0389F2FCQ42013136-EBC8B15D-F191-4024-B9D3-C6348CE032BEQ42033458-4A37FAA6-07E2-4EA0-A2B3-BAFB70AE3249Q43723696-F0AF1BEE-DF0E-4978-A03D-E2DF713CE90DQ52730181-8D793686-26FD-40B5-89B5-0FB5E4A7E9AA
P2860
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ubiquitylation in immune disor ...... s to therapeutic implications.
@en
type
label
Ubiquitylation in immune disor ...... s to therapeutic implications.
@en
prefLabel
Ubiquitylation in immune disor ...... s to therapeutic implications.
@en
P2860
P921
P356
P1476
Ubiquitylation in immune disor ...... s to therapeutic implications.
@en
P2093
Krishnaraj Rajalingam
P2860
P304
P356
10.1002/EMMM.201100707
P577
2012-06-25T00:00:00Z
2012-07-01T00:00:00Z